{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:22:23Z","timestamp":1740108143882,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS 15\/0060"],"award-info":[{"award-number":["FIS 15\/0060"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00430-019-00594-w","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T15:02:45Z","timestamp":1553526165000},"page":"405-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients"],"prefix":"10.1007","volume":"208","author":[{"given":"Alberto","family":"Talaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Vinuesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Amat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Pi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliseo","family":"Albert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Hern\u00e1ndez-Boluda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Solano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"key":"594_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2217\/fvl.14.102","volume":"10","author":"PP Romero","year":"2015","unstructured":"Romero PP, Blanco P, Gim\u00e9nez E, Solano C, Navarro D (2015) An update on the management and prevention of cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation. Future Virol 10:113\u2013134","journal-title":"Future Virol"},{"key":"594_CR2","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","volume":"370","author":"RF Chemaly","year":"2014","unstructured":"Chemaly RF, Ullmann AJ, Stoelben S, Richard MP, Bornh\u00e4user M, Groth C, Einsele H, Silverman M, Mullane KM, Brown J, Nowak H, K\u00f6lling K, Stobernack HP, Lischka P, Zimmermann H, R\u00fcbsamen-Schaeff H, Champlin RE, Ehninger G (2014) Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med 370:1781\u20131789","journal-title":"N Engl J Med"},{"key":"594_CR3","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C (2017) Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med 377:2433\u20132444","journal-title":"N Engl J Med"},{"key":"594_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0092-8674(01)80014-3","volume":"91","author":"C S\u00f6derberg-Naucl\u00e9r","year":"1997","unstructured":"S\u00f6derberg-Naucl\u00e9r C, Fish KN, Nelson JA (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119\u2013126","journal-title":"Cell"},{"key":"594_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(94)91116-9","volume":"343","author":"WD Docke","year":"1994","unstructured":"Docke WD, Prosch S, Fietze E, Kimel V, Zuckermann H, Klug C, Syrbe U, Kr\u00fcger DH, von Baehr R, Volk HD (1994) Cytomegalovirus reactivation and tumor necrosis factor. Lancet 343:268\u2013269","journal-title":"Lancet"},{"key":"594_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/00007890-199409000-00007","volume":"58","author":"E Fietze","year":"1994","unstructured":"Fietze E, Prosch S, Reinke P, Stein J, D\u00f6cke WD, Staffa G, L\u00f6ning S, Devaux S, Emmrich F, von Baehr R (1994) Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 58:675\u2013680","journal-title":"Transplantation"},{"key":"594_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.bbmt.2005.05.013","volume":"11","author":"V Reddy","year":"2005","unstructured":"Reddy V, Meier-Kriesche HU, Greene S, Schold JD, Wingard JR (2005) Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl 11:698\u2013705","journal-title":"Biol Blood Marrow Transpl"},{"key":"594_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1086\/314602","volume":"179","author":"A Humar","year":"1999","unstructured":"Humar A, St Louis P, Mazzulli T, McGeer A, Lipton J, Messner H, MacDonald KS (1999) Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients. J Infect Dis 179:484\u2013488","journal-title":"J Infect Dis"},{"key":"594_CR9","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1128\/JCM.00797-08","volume":"46","author":"C Gimeno","year":"2008","unstructured":"Gimeno C, Solano C, Latorre JC, Hern\u00e1ndez-Boluda JC, Clari MA, Remigia MJ, Furi\u00f3 S, Calabuig M, Tormo N, Navarro D (2008) Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol 46:3311\u20133318","journal-title":"J Clin Microbiol"},{"key":"594_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/TP.0b013e31826c39de","volume":"94","author":"H Rollag","year":"2012","unstructured":"Rollag H, Asberg A, Ueland T, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2012) Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome. Transplantation 94:1060\u20131065","journal-title":"Transplantation"},{"key":"594_CR11","doi-asserted-by":"publisher","first-page":"e60767","DOI":"10.1371\/journal.pone.0060767","volume":"8","author":"H Rollag","year":"2013","unstructured":"Rollag H, Ueland T, Asberg A, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2013) Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma. PLoS One 8:e60767","journal-title":"PLoS One"},{"key":"594_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.diagmicrobio.2012.10.010","volume":"75","author":"MA Clari","year":"2013","unstructured":"Clari MA, Bravo D, Costa E, Munoz-Cobo B, Solano C, Remigia MJ, Gimenez E, Benmarzouk-Hidalgo OJ, Perez-Romero P, Navarro D (2013) Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia. Diag Microbiol Infect Dis 75:207\u2013209","journal-title":"Diag Microbiol Infect Dis"},{"key":"594_CR13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/bmt.2012.286","volume":"48","author":"C Solano","year":"2013","unstructured":"Solano C, Mu\u00f1oz-Cobo B, Gim\u00e9nez E, Remigia MJ, Amat P, Clari MA, Bravo D, Benet I, Montoro J, Navarro D (2013) Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center. Bone Marrow Transpl 48:1010\u20131012","journal-title":"Bone Marrow Transpl"},{"key":"594_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner C, Neiman P, Clift R, Lerner K, Thomas E (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295\u2013304","journal-title":"Transplantation"},{"key":"594_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/cid\/ciy138","volume":"67","author":"E Gim\u00e9nez","year":"2018","unstructured":"Gim\u00e9nez E, Solano C, Vinuesa V, Hern\u00e1ndez-Boluda JC, Albert E, P\u00e9rez A, Pi\u00f1ana JL, Navarro D (2018) Cytomegalovirus DNAemia burden and mortality following allogeneic hematopoietic stem cell transplantation: an area under a curve-based investigational approach. Clin Infect Dis 67:805\u2013807","journal-title":"Clin Infect Dis"},{"key":"594_CR16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/jmv.24450","volume":"88","author":"D Navarro","year":"2016","unstructured":"Navarro D (2016) Expanding role of cytomegalovirus as a human pathogen. J Med Virol 88:1103\u20131112","journal-title":"J Med Virol"},{"issue":"11","key":"594_CR17","doi-asserted-by":"publisher","first-page":"e1001170","DOI":"10.1371\/journal.ppat.1001170","volume":"6","author":"M Shimamura","year":"2010","unstructured":"Shimamura M, Murphy-Ullrich JE, Britt WJ (2010) Human cytomegalovirus induces TGF-\u03b21 activation in renal tubular epithelial cells after epithelial-to- mesenchymal transition. PLoS Pathog 6(11):e1001170","journal-title":"PLoS Pathog"},{"key":"594_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1681\/ASN.2011060628","volume":"23","author":"T Gohda","year":"2012","unstructured":"Gohda T, Niewczas MA, Ficociello LH, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS (2012) Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol 23:516\u2013524","journal-title":"J Am Soc Nephrol"},{"key":"594_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.immunol.16.1.137","volume":"16","author":"JJ Letterio","year":"1998","unstructured":"Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-beta. Annu Rev Immunol 16:137\u2013161","journal-title":"Annu Rev Immunol"},{"key":"594_CR20","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350\u20131358","journal-title":"N Engl J Med"},{"key":"594_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coi.2006.11.008","volume":"19","author":"SM Wahl","year":"2007","unstructured":"Wahl SM (2007) Transforming growth factor-beta: innately bipolar. Curr Opin Immunol 19:55\u201362","journal-title":"Curr Opin Immunol"},{"key":"594_CR22","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/labinvest.3700669","volume":"87","author":"GJ Prud\u2019homme","year":"2007","unstructured":"Prud\u2019homme GJ (2007) Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 87:1077\u20131079","journal-title":"Lab Invest"},{"key":"594_CR23","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1099\/jgv.0.000838","volume":"98","author":"A Talaya","year":"2017","unstructured":"Talaya A, Solano C, Gim\u00e9nez E, Garc\u00eda Gim\u00e9nez JL, Vinuesa V, Alberola J, Pallard\u00f3 FV, Navarro D (2017) Assessing the risk of cytomegalovirus DNAaemia in allogeneic stem cell transplant recipients by monitoring oxidative- stress markers in plasma. J Gen Virol 98:1855\u20131863","journal-title":"J Gen Virol"},{"key":"594_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0022-1759(94)90156-2","volume":"177","author":"A Corti","year":"1994","unstructured":"Corti A, Poiesi C, Merli S, Cassani G (1994) Tumor necrosis factor (TNF) alpha quantification by ELISA and bioassay: effects of TNF alpha-soluble TNF receptor (p55) complex dissociation during assay incubations. J Immunol Methods 177:191\u2013198","journal-title":"J Immunol Methods"},{"key":"594_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1128\/CDLI.6.1.89-95.1999","volume":"6","author":"N Aziz","year":"1999","unstructured":"Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL (1999) Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 6:89\u201395","journal-title":"Clin Diagn Lab Immunol"},{"key":"594_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0049-0172(90)90055-K","volume":"20","author":"DR Schultz","year":"1990","unstructured":"Schultz DR, Arnold PI (1990) Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein and fibrinogen. Sem Arthritis Rheum 20:129\u2013147","journal-title":"Sem Arthritis Rheum"},{"key":"594_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.bmt.1701286","volume":"22","author":"R Schots","year":"1998","unstructured":"Schots R, Kaufman L, Van Riet I, Lacor P, Trullemans F, De Waele M, Van Camp B (1998) Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Bone Marrow Transpl 22:79\u201385","journal-title":"Bone Marrow Transpl"},{"key":"594_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.bmt.1703672","volume":"30","author":"R Schots","year":"2002","unstructured":"Schots R, Van Riet I, Othman TB, Trullemans F, De Waele M, Van Camp B, Kaufman L (2002) An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation. Bone Marrow Transpl 30:441\u2013446","journal-title":"Bone Marrow Transpl"},{"key":"594_CR29","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/sj.leu.2402946","volume":"17","author":"R Schots","year":"2003","unstructured":"Schots R, Kaufman L, Van Riet I, Ben Othman T, De Waele M, Van Camp B, Demanet C (2003) Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 17:1150\u20131156","journal-title":"Leukemia"},{"key":"594_CR30","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1111\/ajt.12836","volume":"14","author":"L Weseslindtner","year":"2014","unstructured":"Weseslindtner L, G\u00f6rzer I, K\u00fcng E, Roedl K, Jaksch P, Klepetko W, Puchhammer-St\u00f6ckl E (2014) High CXCL-16 levels correlate with symptomatic disease in lung transplant recipients with human cytomegalovirus replication in the allograft. Am J Transpl 14:2406\u20132411","journal-title":"Am J Transpl"},{"key":"594_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/TP.0000000000000816","volume":"100","author":"AP Limaye","year":"2016","unstructured":"Limaye AP, La Rosa C, Longmate J, Diamond DJ (2016) Plasma IL-10 levels to guide antiviral prophylaxis prevention of late-onset cytomegalovirus disease, in high risk solid kidney and liver transplant recipients. Transplantation 100:210\u2013216","journal-title":"Transplantation"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00594-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-019-00594-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00594-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T12:11:54Z","timestamp":1587557514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-019-00594-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":31,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["594"],"URL":"https:\/\/doi.org\/10.1007\/s00430-019-00594-w","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"type":"print","value":"0300-8584"},{"type":"electronic","value":"1432-1831"}],"subject":[],"published":{"date-parts":[[2019,3,25]]},"assertion":[{"value":"20 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}